U.S. appeals court invalidates Acorda patents on MS drug

By Jan Wolfe

A U.S. appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door for generic competition for Acorda’s flagship product.

The U.S. Court of Appeals for the Federal Circuit affirmed a lower court ruling that four Acorda patents on Ampyra were invalid because they described obvious ideas. Japanese generic drugmaker Hikma Pharmaceuticals had challenged the validity of the patents.

Acorda’s stock dropped more than 22 percent to $21.40 after the ruling.

  • Related Posts

    • Pharma
    • April 19, 2024
    • 25 views
    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Washington: The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the so-called “boxed warning” to highlight the serious risk of T-cell blood…

    • Pharma
    • April 19, 2024
    • 16 views
    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Bengaluru: A startling revelation has come to light nearly 17,00 fake doctors have been identified in the AYUSH department in Karnataka. Shockingly, despite these discoveries, no significant action has been taken…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    US FDA Mandates Label Updates On CAR-T Cancer Therapies

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Karnataka Fails To Take Action Against 1,700 Fake Doctors

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Chhattisgarh Pharmacy Council Issued Certificates For Hundreds Of Fake Pharmacists Without Verification

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    Gujarat FDCA Approved 133 New Drug Manufacturing Units In FY24

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCGI Informs SLAs Antibiotic Combo Meropenem 1 Mg & EDTA For Injection Has No Approval

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs

    DCA Raids Two Illegal Pharmacies; Seizes Stocks Of Over 60 Types Of Drugs